Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Lexeo Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Lexeo Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Lexeo Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Inozyme Pharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Lexeo Therapeutics, Inc.Listing on record | AwardD (derivative) | — | SEC | |
Inozyme Pharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Inozyme Pharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Inozyme Pharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Inozyme Pharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Vaneltix Pharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $84.3 | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $2.5 | SEC | |
Vaneltix Pharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $0.6 | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $51.1 | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $54 | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $38.5 | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $138.2 | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $1 | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $1K | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $8.7 | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $18.8 | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $14.8 | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $178.2 | SEC | |
Vaneltix Pharma, Inc.Listing unverified | Sell | $99.2 | SEC |